Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fovinaciclib Combinations in Advanced Breast Cancer
NCT05004142Phase 2Unknown
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ongiciclib in breast cancer, sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
ongiciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05004142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004142.